The Scientist

» rare diseases and immunology

Most Recent

Acute bouts of diarrhea could have lasting effects on the microbiota and host immune system activation, a mouse study suggests.

1 Comment

image: This Flu Season Killed 172 Kids

This Flu Season Killed 172 Kids

By Sukanya Charuchandra | June 11, 2018

Vaccination reduced the risk of death by two-thirds for children with no other health problems.  

0 Comments

The receptors, found in so-called elite controllers who don’t need medications to keep the virus in check, suggest a new path toward immunotherapy.

1 Comment

image: New Insights to Improve CAR T Cells’ Safety

New Insights to Improve CAR T Cells’ Safety

By Vicki Brower | June 5, 2018

Drugs approved to treat rheumatoid arthritis block cytokines, the molecules responsible for severe side effects from the immunotherapy, and reduce symptoms in mice.

0 Comments

image: A T-Cell Tweak Combats Advanced Breast Cancer

A T-Cell Tweak Combats Advanced Breast Cancer

By Ashley Yeager | June 5, 2018

The immunotherapy eliminated a woman’s metastatic lesions and kept her disease-free for two years.

0 Comments

image: Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer

Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer

By Sukanya Charuchandra | June 4, 2018

Merck’s Keytruda extended the lives of lung cancer patients by several months and appeared to stop the progression of advanced melanoma.  

0 Comments

Doctors treated the fetus, who has alpha thalassemia major, with cells from her mother’s bone marrow.

0 Comments

Biotechs have developed enzyme replacements and genetically modified probiotics to treat patients with the rare metabolic disorder.

0 Comments

image: Image of the Day: Jasper the Cat

Image of the Day: Jasper the Cat

By The Scientist Staff | May 22, 2018

Researchers found a previously undiscovered hepadnavirus in an immunocompromised cat.

0 Comments

As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull together real-world results.  

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. CRISPR Efficiency Tied to Cancer-Causing Process